Indeed, STAT1 inhibitors SOCS1 and SHP1/2 (component of PTPs) are also commonly hyperactivated in breast cancer [63], and elevated expression of PIAS1 has been observed in prostate and breast cancers [63,64,65]. This evidence concerns the gene PIAS1 and breast carcinoma.